Seneschal Advisors, LLC Viatris Inc Transaction History
Seneschal Advisors, LLC
- $138 Billion
- Q3 2025
A detailed history of Seneschal Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Seneschal Advisors, LLC holds 13 shares of VTRS stock, worth $139. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13Holding current value
$139% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTRS
# of Institutions
1,133Shares Held
966MCall Options Held
7.8MPut Options Held
2.55M-
Vanguard Group Inc Valley Forge, PA140MShares$1.5 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$993 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD84.1MShares$901 Million0.09% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az69.3MShares$743 Million3.68% of portfolio
-
State Street Corp Boston, MA55.7MShares$597 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...